chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On May 9, 2021 I had an urinary tract infection. I was dealing with bladder pain and had blood in my urine. I was experiencing a lot of pain. I went to the doctor. I was prescribed amitriptyline 10mg on July 10, 2021 and I was diagnosed with Interstitial cystitis. She saw a small ulcer and a lot of scattered inflammation.nI saw the urologist on July 13, 2021. She recommended a cystoscopy with hydrodistension. She did a biopsy. I got the procedure done on July 30th, 2021. I am still experiencing some pain and I am still taking the medication I was prescribed.
Light pink/red, slightly raised area on left deltoid that spreads toward inner arm. Patient reports the  area is tender to the touch and he reports a tender arm pit. Patient reports no other symptoms. Verified patient has not had any previous reactions to a vaccine in the past with the patient on 7/1/21.
arms hurts; right arm is twitching; neck hurt; head hurts; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Mar-2021. The most recent information was received on 15-May-2021 and was forwarded to Moderna on 17-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arms hurts), MUSCLE TWITCHING (right arm is twitching), NECK PAIN (neck hurt) and HEADACHE (head hurts) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 002B21A) for COVID-19 vaccination.     The patient's past medical history included Tumor (benign tumor on left side.) and Lichen sclerosis atrophicus in 2019. Concurrent medical conditions included Food allergy (allergic to melon) and Food allergy (allergic to mango). Concomitant products included LEVOTHYROXINE for Thyroiditis.   On 28-Feb-2021 at 12:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021 at 12:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arms hurts), MUSCLE TWITCHING (right arm is twitching), NECK PAIN (neck hurt) and HEADACHE (head hurts). The patient was treated with NAPROXEN at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (arms hurts), MUSCLE TWITCHING (right arm is twitching), NECK PAIN (neck hurt) and HEADACHE (head hurts) outcome was unknown. Not Provided          The patient was given Vitamin and Topical treatment for autoimmune disease as concomitant medication. The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable    Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Follow up is received on 04-may-2021 which contains  added no new information. On 15-May-2021: Follow up is received on 15-may-2021 which contains  patient demographic details, concomitant medications, historical diseases of the patient and second dose details updated. Updated information about facility where vaccine was given.
1/22 Vaccination chills, extreme fatigue, extreme HA. Slept all day and night. Didn't feel better all weekend.  1/29 went to dr. office. Pre-scheduled due to reaction from 1st vaccine.
Fever, confusion, ache, tingling down left side. 3 days in bed.
a large sore under her bottom lip on left side; a large cystic thing that is now a large sore under her bottom lip; a large sore under my bottom lip on left side/it's really on my chin/kin around it is red and my entire chin is peeling; her skin around it was red and her entire chin was peeling; This is a spontaneous report from a contactable consumer (patient).  A 65-year-old female patient (not pregnant) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EN3518), via an unspecified route of administration in Arm Left on 30Jan2021 08:00 at single dose for COVID-19 immunization.  Medical history included meniere's disease, interstitial cystitis, psoriasis.  Concomitant medication included amitriptyline (AMITRIPTYLINE), clonazepam (CLONAZEPAM). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID tested post vaccination and did not have COVID prior vaccination. Known allergies: cefaclor (CECLOR), gadolinium, lactose intolerant, lansoprazole (PREVACID). On 03Feb2021, the patient had a large cystic thing that is now a large sore under her bottom lip on left side. She would say it was really on her chin. As well, her skin around it was red and her entire chin was peeling and had been for several days. She'd never had anything like this before. No treatment was received for the events. The outcome of the events was not recovered.
Information has been received from a 77 year old female registered nurse (R.N.) with codeine allergy who in April 2007, was vaccinated with a dose of ZOSTER (Oka/Merck).  Concomitant therapy included LIPITOR and MSD.  On 07-NOV-2008 the patient began experiencing soreness and tingling/itching under skin at her ribcage.  She then started to break out with a larger rash surrounded by what "looks like 3 spider bites"
This spontaneous report as received from a nurse practitioner refers to a 10 weeks old patient of unknown gender. No information on patient's medical history or concurrent conditions was provided. On 07-JAN-2015, the patient was vaccinated with the dose of PEDVAXHIB lot # K008874 (dose, strength, route of administration and expiration date were not reported) which had temperature excursion. No information on patient's concomitant medication was provided. This is one of several reports from the same reporter. Additional information has been requested.
Information has been received from a physician concerning a patient who on 28-JAN-2009 was vaccinated orally with a dose of ROTATEQ (lot number not reported).  The physician stated that the patient received an incomplete dose of ROTATEQ because the patient vomited immediately after receiving the vaccine.  It was unknown if the patient sought any medical attention.  The outcome of the patient's experience was unknown.  No further information is available.
Received first dose of Moderna on 3/11/2021 and 8 days later developed full body hives. Did many different treatments over the next few months and have seen an allergist who states it?s from the Moderna vaccine and has several other people like me. The hives are now calm but I am classified as having chronic hives now.  Still have itching on my body. I had huge red wets that were very uncomfortable.
On 10/3/8 at 2pm, the patient came to the pharmacy with an area of redness on her left arm. The area went from the injection sites to about 3" above the brachial artery area. It was about 3" to 4" wide.  The patient stated that the area was warm to the touch and had a little tightness in the bicep muscle.  She first noticed the redness on 10/2/18.
The day after the vaccine, I was very weak. I was out of breath when walking up hill when I am use to walking everyday. The weakness lingered. Then a month later, I experienced swelling. I had gained 10 lbs in a week which was water build up. I went to the doctor and was told I had A-fib. I went to a heart specialist 2 days later. I was prescribed Lasix and the swelling went down in 2 days. I am also prescribed Eliquis and blood pressure medication. I have had tests done with my doctor. I have 2 leaky valves. I go tomorrow to get lab work done.
2x5 cm inflammed area rt deltoid sore-very painful to touch; cool compresses; APAP x 5 day;
Janssen COVID-19 Vaccine EUA, chest pain in ribs right side below breast, diminished after 3 days.
This case was reported by a other health professional via call center representative and described the occurrence of slight temperature in a 60-year-old male patient who received SHINGRIX (batch number 75659 ?, expiry date 25th April 2020) for prophylaxis. The reported lot number does not match with any GSK lot number. On 20th February 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fever. On an unknown date, the outcome of the fever was not recovered/not resolved. It was unknown if the reporter considered the fever to be related to SHINGRIX. Additional details were provided as follows: This case was reported by medical assistant (MA). The health care professional stated that the patient experienced persistent low grade fever that remained ongoing. On 11th June 2018, the patient received 2nd dose of SHINGRIX. The health care professional stated that the vaccines were administered at a different facility.  The health care professional was not sure when persistent low grade fever started, only able to provide, sometime after the first dose. The health care professional was unsure how long after the vaccine the fever started.
10/01/03 (11:00)- received her anthrax #5- "right after" she received the injection, she started to feel dizzy- dizziness worsened and she started to experience nausea and vomiting. 10/01/03 (13:30)- went to clinic- at the clinic, she started to develop shortness of breath- because of her history of "heart condition" she was then transferred to the ER. 10/01/03 (15:30)- by the time she arrived at the ER, all her sxs have dissipated on their own- patient was discharged home in stable condition.    According to the patient, she experienced a similar reaction (dizziness and nausea) after she received her first anthrax vaccine (28 March 01)- those sxs lasted few minutes and they resolved on their own.  No adverse reactions experienced with her anthrax #2, #3, and #4.  A copy of the patient's clinical summary sent to VAERS via FedEX on 10/31/03
Child was given adult dose Hep A.  Was reported to CDC and asked for advice of consequences.
Pt received PNEUMOVAX 23 at 1115AM, reported the symptoms on 9/8/10 as swollen, rash, hot red around the area of about 1 inch, hurts when move, no fever, no body ache, looks like fluid inside, pt's sister called by phone to pharmacy.
This spontaneous report as received from a physician via sales representative refers to 3 patients of unknown age. No information about medical history, concurrent conditions and concomitant medications were reported. The reporter stated that on an unknown date after the patients were vaccinated with (Oka-Merck) PROQUAD, route subcutaneous the patients developed large red raised welts in the area of the injection site. The physician also reported to the representative that the three patients also received KNIRIX, along with PROQUAD was administered. The outcome of large red raised welts in the area of the injection site is unknown. The patient sought medical attention. No product quality complaint was involved. Additional information has ben requested.
Following vaccine vaccine  flow VERY HEAVY- never been before , felt shaky and nauseous too
For 7 days post vax, pt acted fussy and clingy. On 7th day post vax, he developed a rash, and then the following day, he developed a fever.
Itchy hives appearing in different spots all over my body roughly 13 days after receiving Moderna booster (3rd dose). Itching relieved with diphenhydramine 50mg.
It started with a runny nose, a headache, and a cough. I did not run a fever. I had body aches. I test myself for COVID-19 and it was positive. I went to the doctor and they did a PCR test and it was positive. I took PAXLOVID for 5 days. Now I have a rebound case of COVID-19.
Menstrual delay/cessation: I am a peri-menopausal woman. I missed only two periods, one year apart, prior to the first shot (not listed here). Upon the first and second shots (3.5 weeks apart), I did not have a period and did not have a subsequent period for four months.  It was the first time in my life I had ever missed more than one period, and I attribute it to the vaccine.  Upon resuming regular, monthly periods in the fifth month, I was regular again. I then got a booster in January 2022. I have not had a period since. I firmly believe this 6+month delay/cessation is due to the vaccine.  I have not changed, increased, or decreased any medication, supplements, etc. I really wanted this data to be included to document the vaccine causes known changes to menstruation.
Hospitalization: 2/22/2023 - 2/25/2023 (3 days); Presentation to the ED: nausea and diarrhea, generalized weakness COVID + date: 2/22/2023; Treatment: Remdesivir; Discharge to: HOME. 205A21A 4/11/2021; 1855194 11/1/2021.
Patient developed small scab/infection near the injection site, approximate size of 3 cm x 2 cm which was noted weeks after administraiton.
HEADACHE; This spontaneous report received from a parent concerned a 19 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included migraine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 01-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAY-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of headache was not reported. This report was non-serious.
patient inadvertently received BEXSERO instead of  MENVEO; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 11-year-old male patient who received Men B NVS (Bexsero) for prophylaxis.   On 17-OCT-2023, the patient received Bexsero. On 17-OCT-2023, an unknown time after receiving Bexsero, the patient experienced wrong vaccine administered (Verbatim: patient inadvertently received BEXSERO instead of  MENVEO). The outcome of the wrong vaccine administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 17-Oct-2023 The reporter was a medical assistant (MA).   The reporter gave consent for follow up. The patient received Bexsero instead of Menveo, which led to wrong vaccine administered.
Diffuse mild swelling of Left upper arm down into hand. Onset 4 days after Moderna vaccine. Continues to have swelling today (11 days after vaccine).
Diarrhoea; headache; Pain in arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Apr-2021 and was forwarded to Moderna on 27-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhoea), HEADACHE (headache) and PAIN IN EXTREMITY (Pain in arm) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced DIARRHOEA (Diarrhoea), HEADACHE (headache) and PAIN IN EXTREMITY (Pain in arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhoea), HEADACHE (headache) and PAIN IN EXTREMITY (Pain in arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant Product included Anxiety medication   This case was linked to US-MODERNATX, INC.-MOD-2021-091890 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-091890:Second dose
This spontaneous report was received from a pharmacist concerning a 83-years-old female patient. The patient had no historical conditions, concurrent conditions, concomitant therapies, historical drugs or allergies. On 25-SEP-2018, the patient was vaccinated with PNEUMOVAX 23 injection, in her right upper arm, reported lot number R006465, expiry date 24-OCT-2019 (strength, dose, route and frequency were not reported) for prophylaxis. On the same date, also reported as later that day, the patient stated that her arm became red, hot, and swollen at and around the injection site (she went to the pharmacy and reported it on 26-SEP-2018). On 26-SEP-2018, also reported as on the evening, the patient called the pharmacy and stated that the symptoms had gotten worse (unspecified). Therefore, she was recommended to use ice and diphenhydramine (BENADRYL) as treatment. No lab diagnostics-studies were performed to the patient due to the events. At the time of the report, the pharmacist stated that he had not heard from the patient since 26-SEP-2018, and that he assumed her symptoms had improved or resolved, but he did not know. The causality assessment between PNEUMOVAX 23 and the events arm became red, hot, and swollen at and around the injection site was not provided.
Patient presented to clinic on 07/24/2023 for Tdap and Meningo vaccines needed for school. Correct Tdap vaccine was pulled from inventory and given in the left deltoid. Correct Meningo vaccine was pulled from inventory around 9:30am but erroneously diluted with 0.5mL sterile water used for live vaccines and given to the patient in the right deltoid around 9:40am. Patient tolerated immunizations well. Printed 3231 for school. Mother and patient were directed to the main lobby to wait 15 minutes. Later that afternoon, around 3:15pm, RN who gave the vaccine realized she had accidentally diluted it that morning, while she was drawing up the same vaccine correctly for a different patient. RN reported to County nurse manager and described the event. RN reached out to District Immunization Coordinator and the District Nurse who was filling in while Coordinator was on vacation. District nurse reached out to the CDC and the State Immunization Program. RN waited to contact parent while a plan was devised. The overall recommendation was for the patient to be appropriately re-vaccinated with MenQuadfi as soon as possible and that the dose given would be counted as ?invalid?. RN received this information on 07/26/2023 and began reaching out to patient's mother via phone. Mother returned RN's calls on 07/28/2023. RN explained incident, significance, and importance of re-vaccinating to receive full protection. Reviewed potential side effects and immune response with mother and addressed her concerns that repeating a dose would be "too much" vaccine. Mother was understanding and agreed to have the child repeat the Menquadfi dose. Scheduled for 07/31/2023. Mother had no further questions. Patient had not experienced adverse reactions.
redness, erythema & discomfort @ inj site;duration 2 days;
syringe lose volume while admiistered; This case was reported by a physician via call center representative and described the occurrence of incomplete dose administered in a 21-month-old female patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2022-2023 season) (batch number K7752, expiry date 30th June 2023) for prophylaxis.   Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Fluarix Tetra 2022-2023 season and Fluarix Tetra Pre-Filled Syringe Device. On an unknown date, unknown after receiving Fluarix Tetra 2022-2023 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced incomplete dose administered. On an unknown date, the outcome of the incomplete dose administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 03-Oct-2022 Reporter's comment: The physician reported that the patient was receiving a Fluarix vaccine, but the syringe lose some volume while the vaccine was administered. The reporter consented to follow up. Additional Supportive Information: The syringe lose volume while the vaccine was administered, which led to incomplete dose administered.
Bumps; Itching at injection site; Breaking out in hives; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Bumps), URTICARIA (Breaking out in hives) and VACCINATION SITE PRURITUS (Itching at injection site) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025821A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included BP medication for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-1900, the patient experienced URTICARIA (Breaking out in hives). On 03-May-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at injection site). On 05-May-2021, the patient experienced SWELLING (Bumps). At the time of the report, SWELLING (Bumps), URTICARIA (Breaking out in hives) and VACCINATION SITE PRURITUS (Itching at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
This spontaneous report was received from a consumer, concerning a 1 year old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On an unspecified date, the patient was vaccinated with one dose of VAQTA (lot #, expiration date, strength, anatomical location or route of administration were not provided), for prophylaxis; but it was expired by 1 month. No adverse effects were reported.
Patient states she has had flu-like symptoms since 7/6/2022 as well as head and neck pain since date of injection.
Mother and patient state that after her last HPV vaccine, she began having vomiting and lower abdominal pain during her menstruation ever since. No treatment given. State that this had occured monthly since her vaccine.
Third day after receiving the vaccine I have been continuously experiencing sparatic and sharp pains mainly in my chest but also in my stomach and occasionally my back. It mainly shows up in my chest. Sharp and achey pains all in different spots at different times. This has been occurring now for 6 days and has not gotten better with time or any medicine I?ve been instructed to take by physician. Sometimes it throbs, sometimes it aches, sometimes it?s sharp and sudden. There is no consistency other than how painful it is. The pain has gotten more intense this evening 1/19/21. I have not experienced more than a half hour without any pain. It has been ongoing since 1/13/21. I woke up last night at 2:45am with a throbbing pain on the left side of my chest.
pt recv vax 8APR96 & same day exp seizure-like rxn which included shaking head from side to side for approx 3 seconds; the episodes occurred numerous times;